InCarda Logo.png
InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones
November 08, 2018 08:05 ET | InCarda Therapeutics, Inc.
Oversubscribed $42 Million Series B Financing Provides Significant Runway to Support Continued Advancement of Innovative Inhaled Cardiovascular Therapy First Patients Dosed in Phase 2 Clinical Trial...
Final CrownBio logo.jpg
Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability
November 08, 2018 08:00 ET | Crown Bioscience
The Company Offers New Non-GLP Services & Translational Rodent Models at its expanded site in Louisiana SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug...
Cardiometabolic Health Congress (CMHC) Concludes 13th Annual Event in Boston
October 29, 2018 10:37 ET | Cardiometabolic Health Congress
Boca Raton, Florida, Oct. 29, 2018 (GLOBE NEWSWIRE) -- As hundreds of participants gathered at the 13th Annual CMHC conference in Boston from October 24-27, an extensive agenda of cutting-edge...
gmi 2018.png
Catheters Market will see 11.3% CAGR to reach $73.5 billion by 2024: Global Market Insights, Inc.
August 16, 2018 06:10 ET | Global Market Insights, Inc
Sellbyville, Delaware, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Global Catheters Market revenue is expected to cross USD 73.5 billion by 2024, says a new Global Market Insights, Inc. report featuring key...
ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update
August 09, 2018 16:15 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Cardiometabolic Health Congress Presents Senior Planning Committee & Chairs
August 09, 2018 11:32 ET | Cardiometabolic Health Congress
Boca Raton, Florida, Aug. 09, 2018 (GLOBE NEWSWIRE) -- CMHC is proud to announce its finalized Senior Planning Committee & Chairpersons for the 2018-2019 season. CMHC has cultivated a...
ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation
July 31, 2018 08:30 ET | ARCA biopharma, Inc.
Single Phase 3 trial may be sufficient for approval of atrial fibrillation indicationPhase 3 clinical trial Special Protocol Assessment submission anticipated 3Q2018Gencaro is in development as...
admera_health_final_logo_transparent_final.jpg
Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test
June 26, 2018 09:13 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com), announced the availability of a psychiatric specific report for its PGxOne™ Plus...
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
June 19, 2018 07:05 ET | Leading BioSciences
CARLSBAD, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
Watson Publishes a Guide to Beta-glucan
May 24, 2018 07:32 ET | Watson Inc
West Haven, CT -, May 24, 2018 (GLOBE NEWSWIRE) -- Americans consume only about half of the daily recommended amount of dietary fiber.  While the new FDA daily value (DV) for fiber is 28 grams, the...